Reports

Report of the General Board on the establishment of the Professorship of Ophthalmology: Amendment

8 July 2019

In the above Report, published on 12 June 2019 (Reporter, 6551, 2018–19, p. 690), it was stated that the tenure of the Professorship would be a fixed term of five years and that the full salary costs would be shared as follows: 50% from Cambridge University Hospitals NHS Trust, 20% from the Van Geest Foundation Fund for Brain Repair and Neuroscience, 20% from the Cambridge Eye Trust, and 10% from Department funds.

The Department of Clinical Neurosciences and the Council of the School of Clinical Medicine have subsequently agreed that the full salary costs of the Professorship will be met from existing resources available to the Department once the already agreed funding for the first five years elapses. The Chair of the Resource Management Committee, on 28 June 2019, accepted this revised funding arrangement and therefore the Chair of the General Board has agreed to amend paragraphs 2 and 3 of the Report, including its recommendation, which have been updated to read as follows:

2. The Board has accepted an academic case from the Faculty Board of Clinical Medicine and the Council of the School of Clinical Medicine for the establishment for a single tenure, from 1 August 2019, of a Professorship of Ophthalmology in the Department of Clinical Neurosciences. The full salary costs of the Professorship for the first five years will be funded as follows: 50% from Cambridge University Hospitals NHS Trust, 20% from the Van Geest Foundation Fund for Brain Repair and Neuroscience, 20% from the Cambridge Eye Trust, and 10% from Department funds. Once this funding elapses, the Professorship will be funded until retirement age from existing resources available to the Department. The Board has agreed that election to the Professorship should be made by an ad hoc Board of Electors and that the candidature should be open to all persons whose work falls within the general field of the title of the office.

3. The General Board recommends:

I. That a Professorship of Ophthalmology be established in the University, for a single tenure, from 1 August 2019 and placed in the Schedule to Special Ordinance C (vii) 1, and assigned to the Department of Clinical Neurosciences.

Second-stage Report of the Council on the construction of a new Heart and Lung Research Institute on the Cambridge Biomedical Campus

The Council begs leave to report to the University as follows:

1. In this Report the Council is seeking approval for the construction of a new Heart and Lung Research Institute on the Cambridge Biomedical Campus as set out below.

2. A First-stage Report for this project was published on 20 April 2016 (Reporter, 6422, 2015–16, p. 474) and approved by Grace 1 of 18 May 2016. This Second-stage Report is to inform the Regent House about further development of the project and to seek approval for construction to proceed.

3. The Cambridge Heart and Lung Research Institute (HLRI) is a joint project between the University and Royal Papworth Hospital NHS Foundation Trust to create a new institute for research into cardiovascular and respiratory disease. Combining the research expertise of the University of Cambridge with the clinical excellence of Royal Papworth Hospital in cardiothoracic medicine and surgery, the aim of the HLRI is to expand and accelerate commercially relevant and high-impact basic and clinical research into new treatments by enabling new collaborations with global pharmaceutical companies, leading medical device companies and a vibrant local biotech sector. The HLRI is a critical component of the long-term strategy of the School of Clinical Medicine to enhance and consolidate research capacity in cardiovascular and respiratory diseases on the Cambridge Biomedical Campus.

4. The HLRI will be located adjacent to the Royal Papworth Hospital. The new building will provide wet and dry laboratories for cell, molecular and translational research, open-plan office accommodation, educational and social space, and a 10-bed clinical research facility. The building will have a gross internal area of approximately 7,950m² and will accommodate around 320 University staff and 70 Royal Papworth Hospital staff.

5. Parking for the HLRI is provided for in the nearby multi-storey car park. Cycle parking and a limited number of disabled parking spaces will be provided within the curtilage of the HLRI site. Contractor parking and other construction logistics will be controlled through a construction management plan to mitigate the impact on existing activities and users of the Biomedical Campus.

6. The target for the HLRI is to achieve the BREEAM Excellent standard. The energy strategy for the building, originally developed in 2016, will be reviewed at RIBA Stage 4 (Detailed Design) to take account of more recent policies and technologies.

7. The University will lease the land for the HLRI from Royal Papworth Hospital NHS Foundation Trust (RPH). The HLRI will be owned and run by the University, with space leased back to RPH for its occupation of around 25% of the total area of the HLRI (being a combination of exclusive demise and shared areas). An Agreement for Lease agreed between the University and RPH provides the University with the necessary rights and access to the land for the purposes of constructing, operating and maintaining the HLRI building.

8. In accordance with the Capital Projects Process, a Full Case has been prepared by the Department of Medicine and was approved by the Planning and Resources Committee on 22 May 2019. The capital cost of the project is estimated to be £65m including land, furniture and equipment. This will be funded as follows: UK Research Partnership Infrastructure Fund (£30m); British Heart Foundation (£10m); Royal Papworth Hospital Charitable Trust (£5m); Royal Papworth NHS Trust (£1.9m); philanthropic donations secured to date (£1.6m); University Capital Fund (£5m). The balance of around £11.5m is expected to come from external fundraising which is ongoing. Any final shortfall will be underwritten by the University.

9. The capital cost of £65m includes allowances for furniture, IT/AV equipment, basic laboratory and clinical research facility fitting-out and decant costs. The School's approach to funding specialist equipment for the HLRI is to re-use existing equipment as far as possible, and to replace this over time in accordance with regular practice for replacing and acquiring new equipment. Funding for specialist equipment will, as now, come from a variety of sources including research grants, collaborative programmes with industry, philanthropic donations, eligible trust funds, and central university funds for equipment.

10. Enabling works are expected to start in autumn 2019. The main construction works are expected to take around 22 months. The HLRI is expected to be in use by Easter Term 2022.

11. Drawings of the proposed development are displayed for the information of the University in the Schools Arcade and are reproduced online at https://www.prao.admin.cam.ac.uk/capital-planning/plans-and-drawings. A plan showing the location of the proposed new building is shown below.

12.The Council recommends:

I. That approval is confirmed for the construction works outlined in this Report.

II. That the Pro-Vice-Chancellor (Strategy and Planning) be authorised to accept a tender for the works, within the available funding, in due course.

12 June 20191	Stephen Toope, Vice-Chancellor	Jennifer Hirst	Michael Proctor
	Sam Ainsworth	Nicholas Holmes	Sofia Ropek-Hewson
	Evie Aspinall	Fiona Karet	Andrew Sanchez
	R. Charles	Christopher Kelly	Sara Weller
	Stephen J. Cowley	Mark Lewisohn	Mark Wormald
	Sharon Flood	Marcel Llavero Pasquina	Jocelyn Wyburd
	Anthony Freeling	Jeremy Morris
	Nicholas Gay	Richard Penty

Location plan: Proposed new Heart and Lung Research Institute on the Cambridge Biomedical Campus